XanaMIA- Here we go again!
Canaccord Genuity (Australia) Ltd analyst Dr Shane Storey initiated coverage of Actinogen Medical on 19 November 2025.
Research written by Canaccord is available to clients of Canaccord. To enquire about access to the report, please contact Dr Shane Story via email at sstorey@cgf.com, or by phone +61 7 5631 2304.
,
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Actinogen. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Actinogen a question about this update.